New COVID drug appears to guard against all variants in people with weak immune systems
A new antibody drug to help fight COVID-19 infection in immune-compromised people may be available by the end of the year.
May 1, 2023
0
135
Organic Chemical: remdesivir
Medical news and research articles
What you need to know about Nipah virus
A mysterious illness causing fevers and headaches and leading to rapid development of acute encephalitis (within a couple of weeks of symptom onset), caused an outbreak of nearly 300 reported cases and over 100 fatalities ...
Apr 20, 2023
0
64
Using organ-on-a-chip technology to elucidate the liver pathophysiology of COVID-19 patients
SARS-CoV-2 infects and causes damage to multiple organs in COVID-19 patients. In particular, liver damage has been associated with COVID-19 severity. However, an understanding of the liver pathophysiology of these patients ...
Mar 8, 2023
0
44
When is remdesivir effective for COVID-19?
Remdesivir was one of the first medications approved for treatment of COVID-19. Clinical studies evaluated its effectiveness, but did not generate conclusive results. A new analysis of the study data shows that a specific ...
Feb 22, 2023
1
53
Researchers show that Paxlovid remains highly effective on omicron variants
Researchers have conducted one of the first studies to examine the effectiveness of nirmatrelvir-ritonavir (Paxlovid) in non-hospitalized patients during an omicron period of the COVID-19 pandemic that includes BA.4 and BA.5 ...
Feb 10, 2023
2
135
Omicron XBB1.5 'Kraken' subvariant appears to be the most transmissible so far
It may feel like history is repeating itself with yet another strain of the SARS-CoV-2 virus driving up cases of COVID-19. The latest is called XBB.1.5 (nicknamed "Kraken," by some), and it's another descendent of the omicron ...
Jan 19, 2023
0
95
Covid treatment gaps highlight persistent health care challenges
Millions of Americans don't have easy access to facilities that dispense oral antiviral treatments for COVID-19, according to a new Yale study. In some parts of the country, researchers found, people have to travel 30 minutes ...
Jan 3, 2023
0
41
New COVID pill may be improvement over Paxlovid, Chinese trial suggests
COVID-19 patients could soon have a new antiviral pill they can take to guard against severe disease.
Dec 30, 2022
0
104
Viewpoint: The UK's COVID treatment and prevention options and how vulnerable people are being forgotten
In February 2022, the UK government abandoned its remaining pandemic restrictions in favor of "living with COVID". This approach relies largely on vaccines protecting people from severe disease.
Dec 21, 2022
0
37
Critical changes in COVID-19 standards of care associated with improved mortality outcomes
An observational study of COVID-19 standard of care (SOC) measures found improvements in recovery and mortality over time in adults hospitalized with COVID-19 and investigated changes in SOC that may explain these improvements. ...
Nov 29, 2022
0
25
